1 Min Read
May 4 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd
* Clinical approvals successfully obtained from CFDA for insulin aspart drug substance and product Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.